Navigation Links
Report answers questions about E. coli: The good, the bad and the deadly

It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry. To enhance public understanding of the bacterium Escherichia coli, the American Academy of Microbiology brought together the nation's leading experts to consider and answer some of the most frequently asked questions about this multifaceted microorganism.

"The story of E. coli, what we are trying to tell in this report, is really much larger than just its role as a pathogen. It's been such a large component of research for so long so much of what we know about biology has come from studying E. coli," says Michael Doyle of the University of Georgia Center for Food Safety, a member of the steering committee.

The report, entitled FAQ E.coli: Good, Bad and Deadly is based on the deliberations of 13 of the nation's leading experts who met for one day in September 2011 to develop clear answers to frequently asked questions regarding the role of E. coli in scientific research, human health and foodborne disease.

Some of the questions considered by the report are:

  • What is E. coli anyway?
  • How has E. coli contributed to our understanding of biology?
  • What does naturally occurring E. coli in our GI tract do?
  • What is the difference between "good" E. coli that inhabits our GI tract and the "bad" E. coli that makes us sick?
  • Why does E. coli make some people sick and not others?
  • How does E. coli become pathogenic?
  • How does our food become contaminated with E. coli?
  • What steps are being taken to protect our food from contamination by pathogenic E. coli?
  • What types of food are most commonly associated with E. coli, and why do there seem to be more cases of contamination recently?

Most answers begin with a simple paragraph summarizing what is known, followed by a more detailed explanation. In addition, spread throughout the report are sidebar boxes discussing issues related to the questions such as a list of Nobel Prizes awarded for work done on E. coli and a discussion of toxins created by the bacterium.

FAQ E. coli: Good, Bad and Deadly is the latest offering in a series of reports designed to provide a rapid response to emerging issues. Traditionally Academy reports are based on multi-day colloquia after which the final report can take up to a year to develop. The FAQ series are based on single-day meetings focused on specific questions after which a final report is published in 2-3 months.

"The Academy FAQ reports explain complex microbiological problems in a timely, balanced format that is easily understandable by the public, the media and policy makers," says Stanley Maloy of San Diego State University, who moderated the colloquium.


Contact: Jim Sliwa
American Society for Microbiology

Related biology news :

1. New report offers broad approach to assessing impacts of ecological damage
2. Report provides new analysis of carbon accounting, biomass use, and climate benefits
3. BGI reports pig parasites genomic sequence provides new clues for parasitic diseases research
4. Aware, Inc. Reports Third Quarter 2011 Financial Results
5. Extreme melting on Greenland ice sheet, reports CCNY team
6. Scientists report major advance in human antibody therapy against deadly Hendra virus
7. Notre Dame researchers report progress on compound to treat neurological diseases
8. Study reports predictors of poor hand hygiene in an emergency department
9. Report showcases success of integrated development approaches
10. Reports highlight the evolving role of clinical microbiology laboratories
11. Researchers report new understanding of role of telomeres in tumor growth
Post Your Comments:
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... Laurin , President and Chief Executive Officer of ProMetic, will ... 27 th Annual Healthcare Conference to be held at ... st , at 8.50am (ET) and ProMetic,s management ... The presentation will be available live via a webcast accessible ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
(Date:11/23/2015)... 23, 2015   Ceres, Inc . (Nasdaq: ... results for the fiscal year ended August 31, 2015 ... --> --> During fiscal year ... feed products with a better balance of yield, energy ... agreements with several leading crop input providers and made ...
Breaking Biology Technology: